Psilocin
4-hydroxy-N,N-dimethyltryptamine
1Provenance card
the boundary, as counts
Sources
4035 with DOI
15 strong · 20 moderate · 5 weak
Compilations
12026-05-03T10:41:16.016Z
pipeline-v5 · prompt hash not recorded — run predates 2026-09
Decisions
30last ruled 2026-06-04
0 awaiting a ruling
Issued documents
62026-10-19T20:33:52.004Z
notice · info card · emergency
Searches
181 with no results
queries and counts on the build
Claims checked
8363 supported
63 supported · 20 not
Correspondence
0received
consent field ships in Phase 4
Edges
271
derivations recorded for this entity
Complete over 40 sources, 1 compilation, and 30 decisions.Not here: the private journal (never).Working material — drafts, discards, unsupported claims — is listed below and readable on the working page.Cite: psychedex.org/substances/psilocin/archive
Timeline
what happened, newest first — claims, searches and artifacts stay inside Build
- 2026-10-19issueIssued emergency
- 2026-10-19issueIssued info_card
- 2026-10-19issueIssued notice
- 2026-09-24srcEffects of Psilocybin-Assisted Therapy on Major Depressive Disorder
- 2026-09-24srcAcute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Subjects
- 2026-09-24srcPsilocybin und Psilocin, zwei psychotrope Wirkstoffe aus mexikanischen Rauschpilzen
- 2026-09-24srcIdentifizierung von Psilocin (Identification of Psilocin)
- 2026-09-24srcElucidating the Phase I metabolism of psilocin in vitro
- 2026-09-24srcPsilocybin with psychological support for treatment-resistant depression: six-month follow-up
- 2026-09-24srcClinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc Analysis
- 2026-09-24srcRecent advances in the neuropsychopharmacology of serotonergic hallucinogens
- 2026-09-24srcSerotonin 5-HT2A, 5-HT2C and 5-HT1A receptor involvement in the acute effects of psilocybin in mice
- 2026-09-24srcPsilocybin dose-dependently causes delayed, transient headaches in healthy volunteers
- 2026-09-24srcModulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience
- 2026-09-24srcReceptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens
- 2026-09-24srcPrevalence and associations of challenging, difficult or distressing experiences using classic psychedelics
- 2026-09-24srcMultiple receptors contribute to the behavioral effects of indoleamine hallucinogens
- 2026-09-24srcThe abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act
- 2026-09-24srcSafety and risk assessment of psychedelic psychotherapy: A meta-analysis and systematic review
- 2026-09-24srcPsilocybin with psychological support for treatment-resistant depression: an open-label feasibility study
- 2026-09-24srcSynthesis and Characterization of Psilocybin Metabolites and Deuterated Analogs
- 2026-09-24srcThe Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future
- 2026-09-24srcPsychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels
- 2026-09-24srcPsilocybin for treatment resistant depression in patients taking a concomitant SSRI medication
- 2026-09-24srcPsilocybin desynchronizes the human brain
- 2026-09-24srcPsychedelics promote plasticity by directly binding to BDNF receptor TrkB
- 2026-09-24srcDevelopment of a PBPK model of psilocybin/psilocin from Psilocybe cubensis (magic mushroom) in mice, rats, and humans
- 2026-09-24srcSingle-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression
- 2026-09-24srcREBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics
- 2026-09-24srcPsychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors
- 2026-09-24srcBroadband Cortical Desynchronization Underlies the Human Psychedelic State
- 2026-09-24srcActivation of serotonin 2A receptors underlies the psilocybin-induced effects on alpha oscillations, N170 visual-evoked potentials, and visual hallucinations
- 2026-09-24srcThe entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs
- 2026-09-24srcUnderlying pharmacological mechanisms of psilocin-induced broadband desynchronization and disconnection of EEG in rats
- 2026-09-24srcThe 'Endless Trip' among NPS Users: Psychopathology and Psychopharmacology in HPPD. A Systematic Review
- 2026-09-24srcTrajectory of Antidepressant Effects after Single- or Two-Dose Administration of Psilocybin: A Systematic Review and Multivariate Meta-Analysis
- 2026-09-24srcPharmacokinetics of Psilocybin: A Systematic Review
- 2026-09-24srcResearch on acute toxicity and the behavioral effects of methanolic extract from psilocybin mushrooms and psilocin in mice
- 2026-09-24srcPsilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance
- 2026-09-24srcLysergic acid diethylamide (LSD) administration selectively downregulates serotonin2 receptors in rat brain
- 2026-09-24srcPsilocin - Wikipedia
- 2026-09-24srcOregon Psilocybin Services Act (Measure 109)
- 2026-09-24srcFrom prohibited to prescribed: The rescheduling of MDMA and psilocybin in Australia
- 2026-09-04issueIssued emergency
- 2026-09-04issueIssued info_card
- 2026-09-04issueIssued notice
- 2026-06-04proposal28 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
- 2026-06-04publicationPublication — backfill
- 2026-05-03revisionRevision 1
- 2026-05-03absenceSearched PubMed for "psilocybin psilocin LD50 lethal dose animal" — no results
- 2026-05-03genGeneration — pipeline-v5pipeline-v5
- 2026-05-03rungeneration run
The same entries, as forms: six forms.